Comprehensive Guideline for Care of Patients With Heart Failure

2014 ◽  
Vol 25 (2) ◽  
pp. 151-162
Author(s):  
Denise Buonocore ◽  
Elizabeth Wallace
Keyword(s):  
Heart Failure ◽  
American Heart ◽  
Heart Association ◽  
The United States ◽  
Clinical Syndrome ◽  
American Heart Association Guideline ◽  
United States Today ◽  
Patients With Heart Failure ◽  
Ventricular Filling

Heart failure (HF) is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. More than 5.1 million people are living with HF in the United States today. This number will continue to rise with the increase in the aging population. With so many people living with HF, nurses need to be well versed on how best to care for them. The 2013 American College of Cardiology Foundation/American Heart Association guideline for the management of HF is a comprehensive guide for all clinicians caring for patients with HF. The updated guideline was developed to assist providers in decision making in the diagnosis and treatment of HF. The goals of the writing committee were to improve quality of care for patients with HF, optimize their outcomes, and improve the efficient use of various resources in the treatment of patients with HF.

scholarly journals Instruments to assess quality of life in patients with heart failure

2015 ◽  
Vol 28 (4) ◽  
pp. 851-858 ◽  
Author(s):  
Amanda Braga de Louredo ◽  
Ana Luiza Coelho Leite ◽  
Gisela Rosa Franco Salerno ◽  
Marcelo Fernandes ◽  
Silvana Blascovi-Assis
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Heart Diseases ◽  
Survival Rates ◽  
Clinical Syndrome ◽  
Metric Properties ◽  
Patients With Heart Failure ◽  
Assess Quality ◽  
Source Of Information

Abstract Introduction : Heart failure (HF) is a complex clinical syndrome representing the common final pathway of various heart diseases. It is characterized by low exercise tolerance, low survival rates and deteriorated quality of life. Several studies mention Quality of Life (QoL) as an important source of information on how disease truly affects patient's lives. In this context, the assessment of QoL is extremely important to provide data that support the choice of a therapeutic strategy and the assessment of the effectiveness of a treatment. Objectives : This study aimed to investigate and identify the most appropriate and widely used instrument for the assessment of quality of life in patients with HF. Methods : We searched the databases of Lilacs, Medline, Pubmed, Scielo and CAPES to identify relevant articles published in English and Portuguese between 2000 and 2010. Results : We found 25 papers that described, quoted or used instruments for the assessment of QoL in patients with HF. Conclusion : The MLHFQ is the most widely used instrument to assess QoL in patients with HF. Its good metric properties have been confirmed in a large number of studies. In addition, it has a simple structure and is easy to administer, which makes it the most recommended instrument for this purpose.

Time of Day and Accurate Weights for Patients With Heart Failure

2012 ◽  
Vol 5 (2) ◽  
pp. 106-115
Author(s):  
Alice M. Siehoff ◽  
Catherine Ryan
Keyword(s):  
Heart Failure ◽  
Heart Association ◽  
The United States ◽  
Early Morning ◽  
Time Of Day ◽  
Optimal Time ◽  
Inclusion Criteria ◽  
Patients With Heart Failure ◽  
Quasi Experimental ◽  
Significant Health

Heart failure (HF) is a significant health problem in the United States. It is estimated that 5.8 million Americans currently live with a diagnosis of HF (American Heart Association, 2010). Despite the fact that daily weight monitoring of patients with HF in the hospital has long been a standard part of monitoring effectiveness of treatment, the literature is lacking recommendations based on evidence specific to the optimal time of day for weighing inpatients. The clinical question under consideration is the following: In hospitalized patients with HF, does consistently measuring weights in the evening compared to early morning accurately reflect differences in net weight gain or loss?In this quasi-experimental, prospective cohort pilot study, 29 patients who met inclusion criteria were weighed in the morning and again in the evening. Results of this study revealed predictable differences for morning (M = 3.09, SD = 2.06) and evening weights (M = 2.47, SD = 1.80); t(28) = −2.602, p = .015. For study patients with three consecutive days of weights (N = 24), Pearson product-moment correlations revealed a statistically significant correlation between individual differences/changes in a.m. and p.m. weights, r(22) = .752, p < .001.The implication for clinical practice is that weights should be measured at a consistent time of day. This may be the morning or evening.

The Role of Cardiac Rehabilitation in Heart Failure Patients

2012 ◽  
Vol 9 (1) ◽  
pp. 61-65
Author(s):  
Melody Sherwood ◽  
Todd M Brown
Keyword(s):  
Heart Failure ◽  
Exercise Training ◽  
Cardiac Rehabilitation ◽  
Pulmonary Rehabilitation ◽  
American Association ◽  
American Heart ◽  
Heart Association ◽  
Patients With Heart Failure ◽  
Cardiovascular Disease Event

The benefit of cardiac rehabilitation (cr) in patients with heart failure is controversial. current American college of cardiology (Acc) and American heart Association (AhA) guidelines for the management of patients with heart failure list exercise training as a class i indication. however, data from clinical trials are mixed, and the current American Association of cardiovascular and Pulmonary rehabilitation (AAcVPr), Acc, and AhA performance measures for the referral to, and delivery of, cr services do not list heart failure as a qualifying cardiovascular disease event for which referral to outpatient cr should occur prior to hospital discharge. in this article, we review the data supporting the benefits of exercise training and formal cr programs in patients with heart failure.

scholarly journals Quality of Care and Outcomes of Older Patients With Heart Failure Hospitalized in the United States and Canada

2005 ◽  
Vol 165 (21) ◽  
pp. 2486 ◽  
Author(s):  
Dennis T. Ko ◽  
Jack V. Tu ◽  
Frederick A. Masoudi ◽  
Yongfei Wang ◽  
Edward P. Havranek ◽  
...  
Keyword(s):  
United States ◽  
Heart Failure ◽  
Quality Of Care ◽  
Older Patients ◽  
The United States ◽  
Patients With Heart Failure

scholarly journals PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF

el–Hayah ◽  
2014 ◽  
Vol 4 (2) ◽  
pp. 81 ◽  
Author(s):  
Lailia Nur Rachma
Keyword(s):  
Heart Failure ◽  
Clinical Manifestations ◽  
The United States ◽  
Clinical Syndrome ◽  
The Body ◽  
Reduced Ejection Fraction ◽  
Patients With Heart Failure ◽  
Male Patients ◽  
Failure Prognosis ◽  
The Cost

<em>Heart failure is a clinical syndrome characterized by abnormalities in the structure or function of the heart, resulting in inability of heart to pump blood to meet the metabolic needs of the body tissue. Heart failure is characterized by clinical manifestations such as circulation congestion, tightness, fatigue, and weakness. Heart failure is a major problem in industrial and developing Country. Currently, the incidence and prevalence of heart failure tends to increase, it is also accompanied by an increase in mortality of heart failure cases. In the United States, 1 million patients hospitalized due to heart failure cases, which contribute to 50,000 deaths each year. While the number of visits to the hospital due to heart failure estimated at 6.5 million. Heart failure prognosis is generally poor despite the patients accepted adequate therapy. From the data obtained, only about 35% of male patients and 50% female patients who survived after the onset of acute heart failure. Generaly, the data obtained high mortality are occurs in patients with grade IV (presence of symptoms at rest) is about 30-70%, grade III (presence of symptoms with mild activity) 10-20%, class II (presence of symptoms when the activity being 5-10 %). Higher mortality was found in older patients, men, patients with reduced ejection fraction, and in patients with coronary disease. Once someone is suffering from heart failure, then he shall bear the very high cost. In America, the cost of issued for heart failure therapy between 15-40 trillion US$. In this review, we will discuss about pathomechanism of heart failure. So it is expected to be a reference to the diagnosis of patients with heart failure, which is expected to be recognized early on that could ultimately improve the quality of heart failure patient life, and reduce the number of mortality due to heart failure</em>

Heart Failure

2014 ◽  
pp. 830-842
Author(s):  
Garrick C. Stewart
Keyword(s):  
Heart Failure ◽  
Poor Quality ◽  
Clinical Syndrome ◽  
The Body ◽  
Structural Abnormality ◽  
Cardiac Diseases ◽  
Cardiac Structure ◽  
Patients With Heart Failure ◽  
End Stage

Heart failure is a complex clinical syndrome occurring in patients with an abnormality of cardiac structure or function that impairs the ability of the heart to fill with or eject blood. Patients with heart failure develop a constellation of symptoms (dyspnea and fatigue) and signs (edema and rales) that lead to frequent hospitalizations, poor quality of life, and a shortened life expectancy. Heart failure has also been defined as the failure of the heart to pump enough blood to meet the metabolic demands of the body, or the ability to do so only at elevated filling pressures. Congestive heart failure is the end stage for many cardiac diseases. Cardiomyopathy refers to any condition in which there is a structural abnormality of the myocardium itself.

Sign in / Sign up

Export Citation Format

Share Document